The effects of individualized exercise prescription combined with remote exercise management on cardiovascular risk factors in overweight and obese patients

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100046307

Enrollment

Unknown

Registered

2021-05-12

Start date

2019-01-01

Completion date

Unknown

Last updated

2021-12-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular disease

Interventions

experimental group:individualized exercise prescription combined with remote management

control group:Health education and self - exercise management

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-65 years, male or female; 2. BMI >= 24kg/m2, stable weight in recent 3 months, sedentary lifestyle; 3. No exercise habit and no other exercise plan; 4. Not dieting to lose weight; 5. Not taking any medications that may affect weight; 6. Informed consent and acceptance of the test.

Exclusion criteria

Exclusion criteria: 1. Secondary obesity or medicated obesity; 2. BMI>=40kg/m2; 3. Unable or unwilling to sign the informed consent; 4. Patients with clearly diagnosed cardiovascular and cerebrovascular diseases (including myocardial infarction, heart failure, atrial fibrillation, atrial flutter, stroke, etc.); 5. Having a clearly diagnosed malignant tumor; 6. Mental illness and cognitive impairment; 7. Persons with severe physical disabilities who cannot be examined; 8. Patients with severe arrhythmia or Brugada syndrome; 9. Pregnant and lactating women; 10. Those who do not have the ability or conditions to perform the exercise according to the test plan; 11. Those who cannot go back to the hospital for review after the intervention; 12. Unable to return the exercise heart rate data.

Design outcomes

Primary

Measure	Time frame
BMI;Systolic pressure;Diastolic pressure;Visceral fat area;Body fat;Body fat percentage;Total cholesterol;Triglycerides;Low density lipoprotein cholesterol;High density lipoprotein cholesterol;Hemoglobin A1c;	—

Secondary

Measure	Time frame
Weight;Waist circumference;Hip circumference;Skeletal muscle;Uric acid;Fasting blood glucose;Fasting insulin;HOMA-IR;	—

Countries

China

Contacts

Public ContactHong Yu

Beijing Rehabilitation Hospital Affiliated to Capital Medical University

y_hong@aliyun.com+86 010-56981108

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 3, 2026